Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in Denmark.

Ehrenstein V, Andersen SL, Qazi I, Sankar N, Pedersen AB, Sikorski R, Acquavella JF.

J Rheumatol. 2017 Oct;44(10):1476-1483. doi: 10.3899/jrheum.160816. Epub 2017 Aug 1.

PMID:
28765257
2.

Estimated number of prevalent cases of metastatic bone disease in the US adult population.

Li S, Peng Y, Weinhandl ED, Blaes AH, Cetin K, Chia VM, Stryker S, Pinzone JJ, Acquavella JF, Arneson TJ.

Clin Epidemiol. 2012;4:87-93. doi: 10.2147/CLEP.S28339. Epub 2012 Apr 10.

3.

Impact of Centers for Medicare & Medicaid Services national coverage determination on erythropoiesis-stimulating agent and transfusion use in chemotherapy-treated cancer patients.

Arneson TJ, Li S, Gilbertson DT, Bridges KR, Acquavella JF, Collins AJ.

Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):857-64. doi: 10.1002/pds.3257. Epub 2012 Mar 26.

PMID:
22450901
4.

Relationship between epoetin alfa dose and mortality: findings from a marginal structural model.

Wang O, Kilpatrick RD, Critchlow CW, Ling X, Bradbury BD, Gilbertson DT, Collins AJ, Rothman KJ, Acquavella JF.

Clin J Am Soc Nephrol. 2010 Feb;5(2):182-8. doi: 10.2215/CJN.03040509. Epub 2009 Dec 17.

5.

Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.

Bradbury BD, Brookhart MA, Winkelmayer WC, Critchlow CW, Kilpatrick RD, Joffe MM, Feldman HI, Acquavella JF, Wang O, Rothman KJ.

Am J Kidney Dis. 2009 Sep;54(3):554-60. doi: 10.1053/j.ajkd.2009.05.010. Epub 2009 Jul 9. Review.

PMID:
19592144
6.

The effect of epoetin dose on hematocrit.

Critchlow CW, Bradbury BD, Acquavella JF, Ruixo JJ, Krishnan M, Chow AT, Brenner RM.

Kidney Int. 2008 Sep;74(6):827; author reply 827-8. doi: 10.1038/ki.2008.281. No abstract available.

7.

Exploring relative mortality and epoetin alfa dose among hemodialysis patients.

Bradbury BD, Wang O, Critchlow CW, Rothman KJ, Heagerty P, Keen M, Acquavella JF.

Am J Kidney Dis. 2008 Jan;51(1):62-70.

PMID:
18155534
8.

Biomonitoring of 2,4-dichlorophenoxyacetic acid exposure and dose in farm families.

Alexander BH, Mandel JS, Baker BA, Burns CJ, Bartels MJ, Acquavella JF, Gustin C.

Environ Health Perspect. 2007 Mar;115(3):370-6. Epub 2006 Dec 14.

9.

Agreement of pesticide biomarkers between morning void and 24-h urine samples from farmers and their children.

Scher DP, Alexander BH, Adgate JL, Eberly LE, Mandel JS, Acquavella JF, Bartels MJ, Brzak KA.

J Expo Sci Environ Epidemiol. 2007 Jul;17(4):350-7. Epub 2006 Jun 21.

PMID:
16788681
10.

Why focus only on financial interests?

Acquavella JF.

Epidemiology. 2006 May;17(3):248-9. No abstract available.

PMID:
16617269
11.

Chlorpyrifos exposure in farm families: results from the farm family exposure study.

Alexander BH, Burns CJ, Bartels MJ, Acquavella JF, Mandel JS, Gustin C, Baker BA.

J Expo Sci Environ Epidemiol. 2006 Sep;16(5):447-56. Epub 2006 Mar 29.

PMID:
16570094
12.

Exposure misclassification in studies of agricultural pesticides: insights from biomonitoring.

Acquavella JF, Alexander BH, Mandel JS, Burns CJ, Gustin C.

Epidemiology. 2006 Jan;17(1):69-74.

PMID:
16357597
13.

Implications for epidemiologic research on variation by pesticide in studies of farmers and their families.

Acquavella JF, Gustin C, Alexander BH, Mandel JS.

Scand J Work Environ Health. 2005;31 Suppl 1:105-9; discussion 63-5.

14.

Biomonitoring for farm families in the farm family exposure study.

Mandel JS, Alexander BH, Baker BA, Acquavella JF, Chapman P, Honeycutt R.

Scand J Work Environ Health. 2005;31 Suppl 1:98-104; discussion 63-5.

15.

Glyphosate results revisited.

Farmer DR, Lash TL, Acquavella JF.

Environ Health Perspect. 2005 Jun;113(6):A365-6; author reply A366-7. No abstract available.

16.

Farm Family Exposure Study: methods and recruitment practices for a biomonitoring study of pesticide exposure.

Baker BA, Alexander BH, Mandel JS, Acquavella JF, Honeycutt R, Chapman P.

J Expo Anal Environ Epidemiol. 2005 Nov;15(6):491-9.

PMID:
15900312
17.

Mortality and cancer incidence among alachlor manufacturing workers 1968-99.

Acquavella JF, Delzell E, Cheng H, Lynch CF, Johnson G.

Occup Environ Med. 2004 Aug;61(8):680-5.

18.

Glyphosate biomonitoring for farmers and their families: results from the Farm Family Exposure Study.

Acquavella JF, Alexander BH, Mandel JS, Gustin C, Baker B, Chapman P, Bleeke M.

Environ Health Perspect. 2004 Mar;112(3):321-6.

19.

An analysis of glyphosate data from the California Environmental Protection Agency Pesticide Illness Surveillance Program.

Goldstein DA, Acquavella JF, Mannion RM, Farmer DR.

J Toxicol Clin Toxicol. 2002;40(7):885-92.

PMID:
12507058
20.

A review of the epidemiology of 1,3-butadiene and chloroprene.

Acquavella JF, Leonard RC.

Chem Biol Interact. 2001 Jun 1;135-136:43-52. Review.

PMID:
11397380
21.

Human ocular effects from self-reported exposures to Roundup herbicides.

Acquavella JF, Weber JA, Cullen MR, Cruz OA, Martens MA, Holden LR, Riordan S, Thompson M, Farmer D.

Hum Exp Toxicol. 1999 Aug;18(8):479-86.

PMID:
10462359
22.

Farming and prostate cancer.

Acquavella JF.

Epidemiology. 1999 Jul;10(4):349-51. No abstract available.

PMID:
10401865
23.

Review and meta-analysis of studies of acrylonitrile workers.

Collins JJ, Acquavella JF.

Scand J Work Environ Health. 1998;24 Suppl 2:71-80.

24.

The politics of identity in epidemiology.

Acquavella JF.

Ann Epidemiol. 1997 Oct;7(7):431-3. Review.

PMID:
9349907
25.

An updated meta-analysis of formaldehyde exposure and upper respiratory tract cancers.

Collins JJ, Acquavella JF, Esmen NA.

J Occup Environ Med. 1997 Jul;39(7):639-51.

PMID:
9253725
26.

Re: "Invited commentary: response to Science article, 'Epidemiology faces its limits'".

Acquavella JF, Ramlow JM.

Am J Epidemiol. 1997 Mar 1;145(5):476. No abstract available.

PMID:
9048522
27.

Toxicology and epidemiology of 1,3-butadiene.

Himmelstein MW, Acquavella JF, Recio L, Medinsky MA, Bond JA.

Crit Rev Toxicol. 1997 Jan;27(1):1-108. Review. No abstract available.

PMID:
9115622
28.

Butadiene epidemiology: a summary of results and outstanding issues.

Acquavella JF.

Toxicology. 1996 Oct 28;113(1-3):148-56. Review.

PMID:
8901894
29.

Evaluation of mortality and cancer incidence among alachlor manufacturing workers.

Acquavella JF, Riordan SG, Anne M, Lynch CF, Collins JJ, Ireland BK, Heydens WF.

Environ Health Perspect. 1996 Jul;104(7):728-33.

30.

Re: "Disclosure of interest: a time for clarity".

Acquavella JF, Collins JJ, Ireland BK, Raabe G, Teta MJ, Chase GR.

Am J Ind Med. 1995 Nov;28(5):609-10; author reply 629-33. No abstract available.

PMID:
8561171
31.

"Farming and prostate cancer mortality".

Ireland B, Acquavella JF, Olsen G.

Am J Epidemiol. 1994 Dec 1;140(11):1057-9. No abstract available.

PMID:
7985657
32.

Interpretation of low to moderate relative risks in environmental epidemiologic studies.

Acquavella JF, Friedlander BR, Ireland BK.

Annu Rev Public Health. 1994;15:179-201. Review. No abstract available.

PMID:
8054080
33.

Organochlorines and breast cancer.

Acquavella JF, Ireland BK, Ramlow JM.

J Natl Cancer Inst. 1993 Nov 17;85(22):1872-5. No abstract available.

PMID:
8129814
34.

Re: "Lymphohematopoietic cancer in styrene-butadiene polymerization workers".

Acquavella JF, Cowles SR.

Am J Epidemiol. 1993 Nov 1;138(9):765-8. No abstract available.

PMID:
8237991
35.

Acute myelogenous leukemia.

Ireland BK, Acquavella JF, Kier LD.

J Natl Cancer Inst. 1993 Jun 2;85(11):920-1. No abstract available.

PMID:
8492321
36.

Perspective on the content of worker notifications.

Acquavella JF, Collins JJ.

Am J Ind Med. 1993 Jan;23(1):77-83.

PMID:
8422063
37.

Risk assessment and industrial health: evaluating the carcinogenic risks of styrene and 1,3-butadiene--an industry viewpoint.

Gelbke HP, Acquavella JF, Fedtke N, Poole A.

IARC Sci Publ. 1993;(127):389-99. Review. No abstract available.

PMID:
8070885
38.

An updated mortality study of workers in three major United States refineries and chemical plants.

Shallenberger LG, Acquavella JF, Donaleski D.

Br J Ind Med. 1992 May;49(5):345-54.

39.

Reconciling old and new findings on dioxin.

Collins JJ, Acquavella JF, Friedlander BR.

Epidemiology. 1992 Jan;3(1):65-9. Review. No abstract available.

PMID:
1554813
40.
41.

An alternative hypothesis for bladder cancer among workers exposed to ortho-toluidine and aniline.

Acquavella JF, Wilson JD, Conner P, Bannister R.

J Natl Cancer Inst. 1991 Nov 20;83(22):1686-7. No abstract available.

PMID:
1749022
42.

A cohort study among workers at a metal components manufacturing facility.

Acquavella JF, Leet TL.

J Occup Med. 1991 Aug;33(8):896-900.

PMID:
1941286
43.

An adenomatous polyp case-control study to assess occupational risk factors following a workplace colorectal cancer cluster.

Acquavella JF, Owen CV, Bird MG, Yarborough CM, Lynch J.

Am J Epidemiol. 1991 Feb 15;133(4):357-67.

PMID:
1994699
44.

Re: "Are non-whites at greater risk for occupational cancer?".

Acquavella JF.

Am J Ind Med. 1991;20(6):811, 813-4. No abstract available.

PMID:
1805619
45.

Future directions in epidemiologic studies of 1,3-butadiene-exposed workers.

Acquavella JF.

Environ Health Perspect. 1990 Jun;86:129-34.

46.

Assessment of colorectal cancer incidence among polypropylene pilot plant employees.

Acquavella JF, Owen CV.

J Occup Med. 1990 Feb;32(2):127-30.

PMID:
2303922
47.

Reasons for participation and nonparticipation in a colorectal cancer screening program for a cohort of high risk polypropylene workers.

Vernon SW, Acquavella JF, Yarborough CM, Hughes JI, Thar WE.

J Occup Med. 1990 Jan;32(1):46-51.

PMID:
2324843
48.

An analysis of death ascertainment and follow-up through statistics Canada's Mortality Data Base system.

Schnatter AR, Acquavella JF, Thompson FS, Donaleski D, Thériault G.

Can J Public Health. 1990 Jan-Feb;81(1):60-5.

PMID:
2311053
49.

Assessment of colorectal cancer screening outcomes among workers involved in polypropylene manufacture.

Acquavella JF, Douglass TS, Vernon S, Hughes JI, Thar WE.

J Occup Med. 1989 Sep;31(9):785-91.

PMID:
2488675
50.

Factors associated with participation in an occupational program for colorectal cancer screening.

Vernon SW, Acquavella JF, Douglass TS, Hughes JI.

J Occup Med. 1989 May;31(5):458-63.

PMID:
2715855

Supplemental Content

Loading ...
Support Center